📢 New Review in #LiversMDPI
🧬 Vemula et al. review second- and third-line strategies after ICI failure in HCC.
🩺 TKIs remain the most widely used second-line option, while evidence for ICI rechallenge remains limited.
đź“– Read More: www.mdpi.com/2673-4389/6/...
